OUR PIPELINE

Abilita Bio is leveraging its EMP™ technology to increase the druggability of challenging multispan membrane proteins and ultimately build a rich pipeline of preclinical stage antibody drugs with blockbuster potential that can be partnered or further developed internally.
Menu